Jump to content

CYP3A7

From Wikipedia, the free encyclopedia

This is the current revision of this page, as edited by Maxim Masiutin (talk | contribs) at 14:20, 24 January 2024 (Used lowercase "cite" template everywhere for consistency. Added the cs1 style template to denote Vancouver ("vanc") citation style, because references contain "vauthors" attribute to specify the list of authors.). The present address (URL) is a permanent link to this version.

(diff) ← Previous revision | Latest revision (diff) | Newer revision → (diff)

CYP3A7
Identifiers
AliasesCYP3A7, CP37, CYPIIIA7, P-450(HFL33), P-450111A7, P450-HFLA, cytochrome P450 family 3 subfamily A member 7, P450HLp2
External IDsOMIM: 605340; MGI: 88610; HomoloGene: 133564; GeneCards: CYP3A7; OMA:CYP3A7 - orthologs
Orthologs
SpeciesHumanMouse
Entrez
Ensembl
UniProt
RefSeq (mRNA)

NM_000765

NM_007819

RefSeq (protein)

NP_000756

NP_031845

Location (UCSC)Chr 7: 99.71 – 99.74 MbChr 5: 137.89 – 137.92 Mb
PubMed search[3][4]
Wikidata
View/Edit HumanView/Edit Mouse

CYP3A7 is an enzyme belonging to the cytochrome P450 family. It is 503 amino acids in size and shares 87% of its sequence with CYP3A4. It carries out a similar role in fetuses that CYP3A4 serves in adults.[5] The gene location is 7q22.1.[6]

The CYP3A group of enzymes are the most abundantly expressed members of the cytochrome P450 family in liver. They are responsible for the metabolism of more than 50% of all clinical pharmaceuticals.[7]

The CYP3A7 enzyme hydroxylates testosterone and dehydroepiandrosterone 3-sulphate, which is involved in the formation of estriol during pregnancy. The CYP3A7 gene is part of a cluster of related genes on chromosome 7q21.1. Naturally-occurring readthrough transcription occurs between this gene and the downstream CYP3A51P pseudogene.[8]

Notable alleles

[edit]

The CYP3A7*1C allele is associated with poor outcomes in some cancer patients, possibly because of the effect of the enzyme on some chemotherapy agents.[9]

References

[edit]
  1. ^ a b c GRCh38: Ensembl release 89: ENSG00000160870Ensembl, May 2017
  2. ^ a b c GRCm38: Ensembl release 89: ENSMUSG00000029727Ensembl, May 2017
  3. ^ "Human PubMed Reference:". National Center for Biotechnology Information, U.S. National Library of Medicine.
  4. ^ "Mouse PubMed Reference:". National Center for Biotechnology Information, U.S. National Library of Medicine.
  5. ^ Komori M, Nishio K, Ohi H, Kitada M, Kamataki T (February 1989). "Molecular cloning and sequence analysis of cDNA containing the entire coding region for human fetal liver cytochrome P-450". J. Biochem. 105 (2): 161–3. doi:10.1093/oxfordjournals.jbchem.a122632. PMID 2722762.
  6. ^ "Cytochrome P450, Subfamily IIIA, Polypeptide 7". OMIM. Retrieved March 14, 2013.
  7. ^ Paulussen A, Lavrijsen K, Bohets H, Hendrickx J, Verhasselt P, Luyten W, Konings F, Armstrong M (July 2000). "Two linked mutations in transcriptional regulatory elements of the CYP3A5 gene constitute the major genetic determinant of polymorphic activity in humans". Pharmacogenetics. 10 (5): 415–24. doi:10.1097/00008571-200007000-00005. PMID 10898111.
  8. ^ Public Domain This article incorporates public domain material from "CYP3A7 cytochrome P450 family 3 subfamily A member 7 [ Homo sapiens (human) ]". Reference Sequence collection. National Center for Biotechnology Information.
  9. ^ "CYP3A7*1C Allele Associated With Poor Outcomes in CLL, Breast, and Lung Cancer". Archived from the original on 2016-06-16. Retrieved 2016-03-27.
[edit]